Trials / Recruiting
RecruitingNCT06926543
Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy
Phase III Randomized Controlled Trial of Sequential Chemotherapy and Radiotherapy Versus Concurrent Chemoradiotherapy in Adjuvant Treatment of Breast Cancer (CONCERT)
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 858 (estimated)
- Sponsor
- Dr. Tabassum Wadasadawala · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical research aims to determine if concurrent chemotherapy and radiation therapy is more effective than sequential chemotherapy and radiation therapy for patients with stage IIB-III breast cancer. It seeks to answer the following key questions: 1. When compared to sequential treatment, does concurrent chemoradiotherapy increase disease-free survival? 2. What effects does concurrent treatment have on post-operative look, quality of life, and side effects including arm swelling (lymphoedema)? 3. What are each treatment approach's financial costs? Researchers will compare the following to groups: Arm A: Participants in the sequential treatment group will first undergo chemotherapy and then radiation. and Arm B: Participants in the concurrent treatment group will undergo radiation therapy while undergoing chemotherapy. Participants are going to: 1. Get the usual chemotherapy (taxanes and/or anthracyclines). 2. Receive radiation therapy for three to four weeks. 3. Have follow-up visits every 6months for 5years to check for cancer recurrence, side effects, and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chemoradiation | This intervention will consist of getting chemotherapy followed by radiotherapy, i.e, in a sequential manner |
| DRUG | Chemoradiation | This intervention will consist of getting chemotherapy and radiotherapy at the same time, i.e, in a concurrent manner. |
Timeline
- Start date
- 2024-05-14
- Primary completion
- 2031-05-01
- Completion
- 2031-05-01
- First posted
- 2025-04-13
- Last updated
- 2025-04-13
Locations
5 sites across 1 country: India
Source: ClinicalTrials.gov record NCT06926543. Inclusion in this directory is not an endorsement.